Immunopathological aspects of age-related macular degeneration

Age-related macular degeneration (AMD) represents a leading cause of blindness worldwide. While the clinical and histopathological aspects of AMD are well characterized, its etiology and pathogenesis remain unclear. Recent findings suggest a role for immunologic processes in AMD pathogenesis, including the age-related generation of extracellular deposits inside the Brusch membrane and beneath the retinal pigment epithelium, recruitment of macrophages for clearance of these deposits, complement activation, recruitment of tissue-destructive macrophages, microglial activation and accumulation, and proinflammatory effects of chronic inflammation by Chlamydia pneumoniae. This review discusses the evidence for the role of inflammation in human AMD and in animal models of AMD.

[1]  A. Munnich,et al.  Structure and refinement of the physical mapping of the γ-glutamylcysteine ligase regulatory subunit (GLCLR) gene to chromosome 1p22.1 within the critically deleted region of human malignant mesothelioma , 1998, Cytogenetic and Genome Research.

[2]  H. Kaplan,et al.  Complement Activation via Alternative Pathway Is Critical in the Development of Laser-Induced Choroidal Neovascularization: Role of Factor B and Factor H1 , 2006, The Journal of Immunology.

[3]  C. Galván,et al.  Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. , 2002, Archives of ophthalmology.

[4]  S. Rodríguez de Córdoba,et al.  The human complement factor H: functional roles, genetic variations and disease associations. , 2004, Molecular immunology.

[5]  K. Csaky,et al.  Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[6]  Y. Tano,et al.  Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration , 2007, Molecular vision.

[7]  N. Rifai,et al.  Association between C-reactive protein and age-related macular degeneration. , 2004, JAMA.

[8]  D. Uhrín,et al.  Structural basis for complement factor H–linked age-related macular degeneration , 2007, The Journal of experimental medicine.

[9]  J. Kowalak,et al.  Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.

[10]  Baitang Ning,et al.  Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Langmann.  Microglia activation in retinal degeneration , 2007, Journal of leukocyte biology.

[12]  L. V. Johnson,et al.  A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.

[13]  C. Jantos,et al.  Chlamydia pneumoniae is not detectable in subretinal neovascular membranes in the exudative stage of age-related macular degeneration. , 2006, Acta ophthalmologica Scandinavica.

[14]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[15]  Hiroyasu Ito,et al.  Chlamydia pneumoniae infection enhances lectin-like oxidized low-density lipoprotein receptor (LOX-1) expression on human endothelial cells. , 2006, FEMS microbiology letters.

[16]  J. Forrester,et al.  The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU). , 2004, Progress in retinal and eye research.

[17]  W. Green,et al.  Granulomatous reaction to Bruch's membrane in age-related macular degeneration. , 1994, Archives of ophthalmology.

[18]  J. Rosenbaum,et al.  IL-1 and TNF receptor-deficient mice show decreased inflammation in an immune complex model of uveitis. , 1999, Investigative ophthalmology & visual science.

[19]  R. Klein,et al.  The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. , 1992, Ophthalmology.

[20]  Y. Jang,et al.  Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium , 2006, Proceedings of the National Academy of Sciences.

[21]  C. Keilhauer,et al.  An update on the genetics of age-related macular degeneration , 2007, Molecular vision.

[22]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[23]  G. Adamus,et al.  EXPERIMENTAL AUTOIMMUNE UVEITIDES: MULTIPLE ANTIGENS, DIVERSE DISEASES , 2002, International reviews of immunology.

[24]  Usha Chakravarthy,et al.  Prevalence of age related maculopathy in northern India , 2004 .

[25]  K. Csaky,et al.  Clinicopathologic correlation of progressive fibrovascular proliferation associated with occult choroidal neovascularization in age-related macular degeneration. , 2004, Archives of ophthalmology.

[26]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[27]  D. Appelt,et al.  Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells , 2003, Journal of neuroscience research.

[28]  M. Gillies,et al.  Immunological and Aetiological Aspects of Macular Degeneration , 2001, Progress in Retinal and Eye Research.

[29]  John D Lambris,et al.  Drusen complement components C3a and C5a promote choroidal neovascularization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  B. Munoz,et al.  Visible light and risk of age-related macular degeneration. , 1990, Transactions of the American Ophthalmological Society.

[31]  W. Green,et al.  Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration. , 2005, Histology and histopathology.

[32]  P. Bora,et al.  CD59, a Complement Regulatory Protein, Controls Choroidal Neovascularization in a Mouse Model of Wet-Type Age-Related Macular Degeneration1 , 2007, The Journal of Immunology.

[33]  H. Grossniklaus,et al.  Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. , 2002, Molecular vision.

[34]  B S Hawkins,et al.  Epidemiology of age-related macular degeneration. , 1999, Molecular vision.

[35]  J. Forrester.  Macrophages eyed in macular degeneration , 2003, Nature Medicine.

[36]  Sonia H Yoo,et al.  Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. , 2003, Survey of ophthalmology.

[37]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[38]  R. D'Agostino,et al.  Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. , 2003, The Journal of clinical investigation.

[39]  Robert W. Massof,et al.  Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study. , 2004, Archives of ophthalmology.

[40]  P. Farrell.  Overstaying their welcome: defective CX3CR1 microglia eyed in macular degeneration , 2007 .

[41]  P. Debré,et al.  CX 3 CR 1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration , 2007 .

[42]  P. Campochiaro,et al.  Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. , 1998, The American journal of pathology.

[43]  J. McNeil,et al.  Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration. , 2005, American journal of epidemiology.

[44]  P. Mcgeer,et al.  Complement activation by beta-amyloid in Alzheimer disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Walport,et al.  Complement. Second of two parts. , 2001, The New England journal of medicine.

[46]  Benita J. O’Colmain,et al.  Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.

[47]  Eiji Sakurai,et al.  An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice , 2003, Nature Medicine.

[48]  Johanna M Seddon,et al.  The genetics of age-related macular degeneration: a review of progress to date. , 2006, Survey of ophthalmology.

[49]  Yoshimasa Yamamoto,et al.  Chlamydia pneumoniae Infection Induces Differentiation of Monocytes into Macrophages , 2002, Infection and Immunity.

[50]  H. Grossniklaus,et al.  Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. , 1991, American journal of ophthalmology.

[51]  D. Patel,et al.  Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow , 1998, The Journal of experimental medicine.

[52]  S. Meri,et al.  Factor H and disease: a complement regulator affects vital body functions. , 1999, Molecular immunology.

[53]  J. Lambris,et al.  Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. , 1985, The Biochemical journal.

[54]  An apolipoprotein E variant may protect against age‐related macular degeneration through cytokine regulation , 2006 .

[55]  P. Zipfel,et al.  Complement and diseases: defective alternative pathway control results in kidney and eye diseases. , 2006, Molecular immunology.

[56]  Alexander J. Rivest,et al.  The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[57]  P. Mitchell,et al.  Exposure to Chlamydia pneumoniae infection and age-related macular degeneration: the Blue Mountains Eye Study. , 2007, Investigative ophthalmology & visual science.

[58]  Ammarin Thakkinstian,et al.  Systematic review and meta-analysis of the association between complementary factor H Y402H polymorphisms and age-related macular degeneration , 2006 .

[59]  Purushottam Jha,et al.  Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. , 2005, Journal of immunology.

[60]  R. Klein,et al.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.

[61]  A. Dick,et al.  Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/c+CD4low parenchymal microglia. , 1995, The British journal of ophthalmology.

[62]  M. Al-Ubaidi,et al.  Retina-derived microglial cells induce photoreceptor cell death in vitro , 1999, Brain Research.

[63]  Joan W. Miller,et al.  Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[64]  P. Debré,et al.  CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. , 2007, The Journal of clinical investigation.

[65]  P. Jong.  Prevalence of age-related macular degeneration in the United States. , 2004 .

[66]  M. A. Mandal,et al.  Complement factor H: spatial and temporal expression and localization in the eye. , 2006, Investigative ophthalmology & visual science.

[67]  T. Salt,et al.  Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction , 2007, Proceedings of the National Academy of Sciences.

[68]  J. Forrester,et al.  Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. , 2007, Experimental eye research.

[69]  J. Ambati,et al.  Macrophage depletion inhibits experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[70]  Masaru Miyagi,et al.  Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[71]  G. Abecasis,et al.  Meta-analysis of genome scans of age-related macular degeneration. , 2005, Human molecular genetics.

[72]  A. Hofman,et al.  C-reactive protein level and risk of aging macula disorder: The Rotterdam Study. , 2007, Archives of ophthalmology.

[73]  C. Chan,et al.  Immunopathology of uveitis , 1985, The British journal of ophthalmology.

[74]  U. Schlötzer-Schrehardt,et al.  Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. , 2007, Molecular immunology.

[75]  B. Rollins,et al.  Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.

[76]  Yasser M. Abdelrahman,et al.  The chlamydial developmental cycle. , 2005, FEMS microbiology reviews.

[77]  F. Salamanca-Gómez.  [Complement factor H and macular degeneration]. , 2005, Gaceta medica de Mexico.

[78]  Alexander J. Rivest,et al.  The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[79]  J. Vander.  Risk Factors for the Incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 19Milton RC, for the Age-Related Eye Disease Study Research Group (EMMES Corp, Rockville, Md; et al) Ophthalmology 112:533–539, 2005§ , 2006 .

[80]  E. Chew,et al.  The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age‐related macular degeneration , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[81]  M. Boulton,et al.  The role of oxidative stress in the pathogenesis of age-related macular degeneration. , 2000, Survey of ophthalmology.

[82]  Ayyakkannu Manivannan,et al.  Age‐dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice , 2008, Aging cell.

[83]  S. Ito,et al.  Pathogenic role of retinal microglia in experimental uveoretinitis. , 2003, Investigative ophthalmology & visual science.

[84]  S. Lightman,et al.  Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? , 2006, Clinical medicine & research.

[85]  L. V. Johnson,et al.  Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.

[86]  S. Russell,et al.  Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[87]  R. Apte,et al.  Macrophages Inhibit Neovascularization in a Murine Model of Age-Related Macular Degeneration , 2006, PLoS medicine.

[88]  T. Hisatomi,et al.  The critical role of ocular‐infiltrating macrophages in the development of choroidal neovascularization , 2003, Journal of leukocyte biology.

[89]  Justine R. Smith,et al.  Basic pathogenic mechanisms operating in experimental models of acute anterior uveitis , 1998, Immunology and cell biology.

[90]  Wiklund Ra,et al.  First of two parts , 1997 .

[91]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[92]  Don H. Anderson,et al.  Y402H Polymorphism of Complement Factor H Affects Binding Affinity to C-Reactive Protein1 , 2007, The Journal of Immunology.

[93]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[94]  M. Kamei,et al.  Scavenger receptors for oxidized lipoprotein in age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.

[95]  S. Russell,et al.  Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[96]  K. Ley,et al.  Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[97]  R. Klein,et al.  Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.

[98]  Johanna M Seddon,et al.  Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. , 2003, Ophthalmology.

[99]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[100]  A. Milam,et al.  Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. , 2003, Experimental eye research.

[101]  J. Rosenbaum,et al.  Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells. , 2003, Investigative ophthalmology & visual science.

[102]  P. Mitchell,et al.  The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples. , 2007, Investigative ophthalmology & visual science.

[103]  J. Hoh,et al.  Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. , 2006, Human molecular genetics.

[104]  Y. Ogura,et al.  Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice. , 2007, Investigative ophthalmology & visual science.